Publications by Computational Biology and Bioinformatics Dorigatti, I. et al. (2021) “Author Correction: SARS-CoV-2 antibody dynamics and transmission from community-wide serological testing in the Italian municipality of Vo’”, Nature Communications, 12(1), p. 5020. Mishra, S. et al. (2021) “Comparing the responses of the UK, Sweden and Denmark to COVID-19 using counterfactual modelling”, Scientific Reports, 11. Redd, R. et al. (2021) “Behavioural responses to SARS-CoV-2 antibody testing in England: REACT-2 study”, Wellcome Open Research, 6, p. 203. Williams, L. et al. (2021) “Measuring vaccine efficacy against infection and disease in clinical trials: sources and magnitude of bias in COVID-19 vaccine efficacy estimates”, p. 2021.07.30.21260912. Ward, H. et al. (2021) “Increasing SARS-CoV-2 antibody prevalence in England at the start of the second wave: REACT-2 Round 4 cross-sectional study in 160,000 adults”, p. 2021.07.21.21260926. Gold, S. et al. (2021) “Modelling the influence of naturally acquired immunity from subclinical infection on outbreak dynamics and persistence of rabies in domestic dogs”, PLoS Neglected Tropical Diseases, 15(7). Hillis, S. et al. (2021) “Under the radar: global minimum estimates for COVID-19-associated orphanhood and deaths among caregivers”, Lancet, 398(10298), pp. 391–402. Dorigatti, I. et al. (2021) “SARS-CoV-2 antibody dynamics and transmission from community-wide serological testing in the Italian municipality of Vo’”, Nature Communications, 12. Ward, H. et al. (2021) “Vaccine uptake and SARS-CoV-2 antibody prevalence among 207,337 adults during May 2021 in England: REACT-2 study”, p. 2021.07.14.21260497. Bennett, S., Cucuringu, M. and Reinert, G. (2021) “Detection and clustering of lead-lag networks for multivariate time series with an application to financial markets”, in. Previous page ‹‹ … Page 25 Page 26 Page 27 Page 28 Current page 29 Page 30 Page 31 Page 32 Page 33 … Next page ››